Clinical Trials List
2024-04-01 - 2028-08-03
Phase II
Recruiting5
ICD-10B96.89
Other specified bacterial agents as the cause of diseases classified elsewhere
ICD-9041.85
Other Gram-negative organisms infections of unspecified site
xxxxxx
-
Sponsor
xxxxxx
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 吳怡萱 Division of Pediatrics
- 林瑞瑩 Division of Pediatrics
- 許凱翔 Division of Pediatrics
- 楊長佑 Division of Pediatrics
- 江明洲 Division of Pediatrics
- 林建志 Division of Pediatrics
- Jen Fu Hsu Division of Pediatrics
- 傅仁煇 Division of Pediatrics
- 陳米琪 Division of Pediatrics
- 朱世明 Division of Pediatrics
- 李恩沛 Division of Pediatrics
- 夏紹軒 Division of Pediatrics
- 陳建彰 Division of Pediatrics
- 賴美吟 Division of Pediatrics
- 李建忠 Division of Pediatrics
- 郭貞孍 Division of Pediatrics
- Ming-Wei Lai Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 徐仲庭 Division of Pediatrics
- CHIA -MAN CHOU Division of Pediatrics
- 林怡瑄 Division of Pediatrics
- 潘蕙嫻 Division of Pediatrics
- PO - YEN CHEN Division of Pediatrics
- 許雅淇 Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- I-JUNG TSAI Division of Pediatrics
- Luan-Yin Chang Division of Pediatrics
- Chun-yi Lu Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Metronidazole
Dosage Form
270
Dosage
500 mg/100 mL
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
48 participants
